Opus Genetics (IRD) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.97% |
| Dec 31, 2025 | 46.40% |
| Sep 30, 2025 | -5.02% |
| Jun 30, 2025 | -22.42% |
| Mar 31, 2025 | 37.86% |
| Dec 31, 2024 | -17.16% |
| Sep 30, 2024 | -11.61% |
| Jun 30, 2024 | -12.20% |
| Mar 31, 2024 | -6.61% |
| Dec 31, 2023 | 19.11% |
| Sep 30, 2023 | 6.00% |
| Jun 30, 2023 | 2.60% |
| Mar 31, 2023 | -8.55% |
| Dec 31, 2022 | 207.72% |
| Sep 30, 2022 | -18.62% |
| Jun 30, 2022 | -11.54% |
| Mar 31, 2022 | -21.55% |
| Dec 31, 2021 | 10.27% |
| Sep 30, 2021 | -8.19% |
| Jun 30, 2021 | 128.69% |
| Mar 31, 2021 | -35.38% |
| Dec 31, 2020 | 102.97% |
| Sep 30, 2020 | -12.26% |
| Jun 30, 2020 | -16.27% |
| Mar 31, 2020 | 615.56% |
| Dec 31, 2019 | -80.62% |
| Sep 30, 2019 | 8.51% |
| Jun 30, 2019 | 19.39% |
| Mar 31, 2019 | -29.98% |
| Dec 31, 2018 | 90.44% |
| Sep 30, 2018 | -9.87% |
| Jun 30, 2018 | -19.12% |
| Mar 31, 2018 | -29.23% |
| Dec 31, 2017 | 8.18% |
| Sep 30, 2017 | -6.42% |
| Jun 30, 2017 | -16.17% |
| Mar 31, 2017 | -9.43% |
| Dec 31, 2016 | 37.97% |
| Sep 30, 2016 | 6.53% |
| Jun 30, 2016 | -24.71% |
| Mar 31, 2016 | 2.59% |
| Dec 31, 2015 | -18.08% |
| Sep 30, 2015 | 24.87% |
| Jun 30, 2015 | -7.07% |
| Mar 31, 2015 | 9.19% |
| Dec 31, 2014 | -34.37% |
| Sep 30, 2014 | -60.71% |
| Jun 30, 2014 | -4.91% |
| Mar 31, 2014 | 114.43% |
| Dec 31, 2013 | 25.67% |
| Sep 30, 2013 | 49.02% |
| Jun 30, 2013 | -17.31% |
| Mar 31, 2013 | -10.51% |
| Dec 31, 2012 | 82.74% |
| Sep 30, 2012 | -13.00% |
| Jun 30, 2012 | 4.71% |
| Mar 31, 2012 | -17.85% |
| Dec 31, 2011 | -25.39% |
| Sep 30, 2011 | -18.05% |
| Jun 30, 2011 | -21.38% |
| Mar 31, 2011 | 66.23% |
| Dec 31, 2010 | -22.04% |
| Sep 30, 2010 | -11.14% |